Novel synthesized trimannose conjugate induces endocytosis and expression of immunostimulatory molecules in monocytic leukemia cells.
Macrophage mannose receptor (MMR) recognizes the pattern of carbohydrates exposed on microorganisms and mediates endocytosis in macrophages. We have synthesized glycoconjugate cationic polymers carrying 3,6-branched alpha-D-mannoside, a trimannose conjugate (TMC) with a high affinity for mannose-specific lectins. Culture with 10 microM TMC for 6 hours induced adhesion and aggregation in NKM-1, a human myelomonocytic leukemia cell line. TMC also stimulated the accumulation of fluorescein isothiocyanate (FITC)-dextran (FITC-DX). This accumulation seemed to be mediated by endocytosis via MMR because mannan, which specifically binds to MMR, inhibited FITC-DX accumulation. Expression of CD14, adhesion molecules, and costimulatory molecules was induced for 24 hours in NKM-1 and in fresh leukemia blasts from 4 patients with acute myeloid leukemia (AML) M4 and M5 subtypes (French-American-British classification). To clarify the binding mechanism, we compared mannose conjugates and a monomer of mannose regarding their effects on endocytosis and enhancement of CD14 and CD86 expression. A polymer of monomannose clusters with a lower affinity for lectins slightly stimulated exdocytosis, whereas a monomer of trimannose had no effect. These findings suggest that concatenation between MMR and TMC may play an important role in the activation of monocytic leukemia cells. TMC may become a good candidate to target MMRs of leukemia cells.
Kanbe
E
E
First Department of Internal Medicine, Graduate School of Medicine, Nagoya University, Japan.
Emi
N
N
Abe
A
A
Tanaka
H
H
Kobayashi
K
K
Saito
H
H
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000378:metabolism*; D015703:Antigens, CD / Q000187:drug effects / Q000378:metabolism; D051940:B7-2 Antigen; D001854:Bone Marrow Cells / Q000187:drug effects / Q000473:pathology; D002448:Cell Adhesion / Q000187:drug effects; D003911:Dextrans / Q000493:pharmacokinetics; D004705:Endocytosis / Q000187:drug effects*; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D006801:Humans; D016130:Immunophenotyping; D037181:Lectins, C-Type; D007951:Leukemia, Myeloid / Q000276:immunology / Q000473:pathology*; D018950:Lipopolysaccharide Receptors / Q000187:drug effects / Q000378:metabolism; D008264:Macrophages / Q000737:chemistry; D008358:Mannose / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology*; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000378:metabolism; D015394:Molecular Structure; D011956:Receptors, Cell Surface / Q000378:metabolism / Q000502:physiology; D014312:Trisaccharides / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D051940:B7-2 Antigen; C497964:CD86 protein, human; D003911:Dextrans; D037181:Lectins, C-Type; D018950:Lipopolysaccharide Receptors; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D014312:Trisaccharides; C015219:fluorescein isothiocyanate dextran; D016650:Fluorescein-5-isothiocyanate; D008358:Mannose